Gujarat Themis Biosyn merger & restructuring announcements

Merger & RestructuringGujarat Themis Biosyn Ltd GUJTHEM

Gujarat Themis Biosyn Merger & Restructuring Worth ₹1.11 Cr

Gujarat Themis Biosyn incorporated a wholly owned pharmaceutical subsidiary in Ireland with €1,00,000 capital. The move marks an international expansion into European markets.

Value

₹1.11 Cr

Merger & RestructuringGujarat Themis Biosyn Ltd GUJTHEM

Gujarat Themis Biosyn Merger & Restructuring

Gujarat Themis Biosyn Limited incorporated a wholly owned subsidiary, Themis Biosyn Japan Limited, in Japan. This strategic expansion marks the company's direct entry into the Japanese market.

Merger & RestructuringGujarat Themis Biosyn Ltd GUJTHEM

Gujarat Themis Biosyn Merger & Restructuring Worth ₹0.61 Cr

Gujarat Themis Biosyn incorporated a wholly owned subsidiary in Japan named Themis Biosyn Japan Limited. This expansion strengthens the company's international pharmaceutical business footprint.

Value

₹0.61 Cr